Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed) | PAR 21 080

Opportunity Information: Apply for PAR 21 080

The National Institutes of Health (NIH) is offering a discretionary research grant opportunity under Funding Opportunity Announcement (FOA) PAR-21-080, titled "Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed)." This program uses the R01 mechanism and is intended to fund innovative, investigator-driven research that improves understanding of why some immigrant groups experience worse health outcomes (health disparities) while others show better-than-expected outcomes (health advantages). A key emphasis is on factors that are uniquely tied to the immigration experience itself, rather than broadly studying health outcomes in racial or ethnic groups without attention to immigration-related exposures.

The central goal is etiologic research, meaning studies that identify and explain the causes and pathways that lead to health disadvantages or advantages among U.S. immigrant populations. Projects supported by this FOA should focus on immigration-specific contexts, exposures, and mechanisms that shape health across the life course and across generations. This can include, for example, how pre-migration conditions, the migration journey, legal and documentation status, acculturation and enculturation processes, discrimination and xenophobia, changes in social networks, language access, employment conditions, neighborhood context, or interaction with U.S. institutions influence physical and mental health. The FOA is also aimed at understanding protective factors that may contribute to immigrant health advantages, such as strong family cohesion, cultural practices, community support, or health behaviors that differ from U.S.-born populations.

The announcement specifies that clinical trials are not allowed, which typically means applicants should not propose studies that prospectively assign human participants to an intervention to evaluate effects on health outcomes. Instead, the FOA is aligned with observational, mechanistic, and explanatory research designs, including analyses of existing datasets, longitudinal cohort studies without intervention assignment, natural experiments, mixed-methods research that clarifies causal pathways, and community-engaged or implementation-relevant observational work, as long as it does not cross into a clinical trial as defined by NIH. In practical terms, applicants should design studies to identify determinants and mechanisms rather than test an intervention for efficacy.

Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants listed for this opportunity include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; Native American tribal organizations that are not federally recognized governments; nonprofit organizations both with and without 501(c)(3) status (as long as they are not institutions of higher education when applying under those categories); for-profit organizations other than small businesses; and small businesses. The FOA also highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, Indian/Native American Tribal Governments other than federally recognized, and U.S. territories or possessions. This breadth is meant to encourage participation from institutions that are closely connected to immigrant communities and from organizations with the capacity to conduct rigorous health research.

At the same time, the FOA draws important boundaries regarding foreign involvement. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are not eligible to apply. However, the FOA allows "foreign components" as defined in the NIH Grants Policy Statement, meaning a U.S.-based applicant may include certain elements of work conducted outside the United States when scientifically justified and compliant with NIH policy (for instance, limited data collection or collaboration that is essential to understanding pre-migration or migration-related exposures). The overall intent remains centered on U.S. immigrant populations and U.S.-relevant health outcomes.

From an administrative standpoint, this is a grant (Funding Instrument Type: Grant) in the Health-related federal activity category, with associated CFDA numbers 93.113, 93.273, 93.307, 93.399, and 93.866. The FOA record shows a creation date of November 17, 2020, and an original closing date of January 7, 2023. The listing does not provide an award ceiling or expected number of awards in the provided source details, which usually indicates applicants should refer to the full FOA text and NIH institute-specific guidance for budget expectations and likely funding levels.

Overall, PAR-21-080 is designed for researchers and community-aligned institutions seeking to explain how immigration-related exposures and contexts shape health, with the explicit aim of advancing knowledge about both health inequities and unexpected health resilience among immigrant groups in the United States. The emphasis is on strong conceptual models, careful measurement of immigration experiences, and rigorous study designs that can clarify causal pathways without proposing a clinical trial.

• The National Institutes of Health in the education, environment, health sector is offering a public funding opportunity titled "Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113, 93.273, 93.307, 93.399, 93.866.
• This funding opportunity was created on 2020-11-17.
• Applicants must submit their applications by 2023-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 21 080

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: